Matinas BioPharma | Investor Presentation Deck | 29 slides · page 25 of 29
The slide uses a line chart to show weight loss over 22 days, highlighting that IV-Docetaxel causes significant weight loss (toxicity) while oral LNC-Docetaxel maintains weight similar to control.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 chart 1/1 list 1/1 source-note 1/1 title 1/1
Components 5
primary line bullet source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.